share_log

EXCLUSIVE: Next-Generation Psychedelics, MEAI - How And Why, An Israeli Scientist Explains

EXCLUSIVE: Next-Generation Psychedelics, MEAI - How And Why, An Israeli Scientist Explains

獨家:下一代迷幻藥,MEAI-以色列科學家如何以及為什麼解釋
Benzinga Real-time News ·  2023/01/23 11:28
(This is part two of a four-part series)
(這是四部分系列的第二部分)
Check out part one in the series: Next-Generation Psychedelics: The Case Of MEAI And Its Potential To Treat Addiction
查看系列中的第一部分: 下一代迷幻藥:MEAI 的案例及其治療成癮的潛力
A compound developed by Israeli psychedelics company Clearmind Medicine (NASDAQ:CMND) would act by providing a similar feeling to that which drinking alcohol produces.
由以色列迷幻藥公司 Clearmind 醫學(NASDAQ:CMND)開發的化合物將通過提供類似的感覺,飲用酒精產生的行為。
"It gives you the sensation not only that you've had enough but also you don't want to have any more drinks, while also giving a very warm, very controlled sociable sensation," says CEO Dr. Adi Zuloff-Shani.
首席執行官說:「這不僅給您帶來了足夠的感覺,而且您不想再喝任何飲料,同時還給人一種非常溫暖,非常可控的社交感覺。」 阿迪·祖洛夫·沙尼博士。
Clearmind has already concluded several preclinical studies on...
Clearmin...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論